AzTrials
AzTrials

PregnancyPhase 2/3NCT00282204

Hypnosis Antenatal Training for Childbirth (HATCh): a Randomised Controlled Trial

A Phase 2/3 study testing antenatal hypnosis + audio compact disc on hypnosis and Audio compact disc on hypnosis in people with Pregnancy and Labor, run by Women's and Children's Hospital, Australia at 1 site in Australia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Pregnancy, Labor
What is being tested?
antenatal hypnosis + audio compact disc on hypnosis and Audio compact disc on hypnosis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
448 participants
Where
1 siteAustralia
Study dates
Dec 2005to Dec 2010
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • women > 34 < 39 weeks gestation; singleton, viable fetus, vertex presentation, who are not in active labour (active labour is defined as cervical effacement and dilatation associated with regular uterine contractions) and who are planning a vaginal birth.

Who cannot join

  • Previous hypnosis preparation for childbirth;
  • poor understanding of English requiring translator;
  • women who are already enrolled in another pregnancy trial where analgesia requirements are an outcome measure;
  • active psychological or psychiatric problems such as: active depression requiring treatment by a psychiatrist;
  • schizophrenia;
  • prior psychosis;
  • severe intellectual disability.
  • Women with pain caused by specific pathological entities such as: congenital neuromuscular disorders; spina bifida; metastatic disease; osteoporosis; rheumatoid arthritis; fractures,are also excluded

Trial locations and contacts

1 site in 1 country.

Australia1 site
  • Women's and Children's Hospital

    Adelaide, South Australia, 5006

Other trials in Australia

About this study

Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy.

Read the detailed description

Background: Although medical interventions play an important role in preserving lives and maternal comfort they have become increasingly routine in normal childbirth. This may increase the risk of associated complications and a less satisfactory birth experience. Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy.

Methods / Design: A single centre, randomised controlled trial using a 3 arm parallel group design in the largest tertiary maternity unit in South Australia. Group 1 participants receive antenatal hypnosis training in preparation for childbirth administered by a qualified hypnotherapist with the use of an audio compact disc on hypnosis for re-enforcement; Group 2 consists of antenatal hypnosis training in preparation for childbirth using an audio compact disc on hypnosis administered by a nurse with no training in hypnotherapy; Group 3 participants continue with their usual preparation for childbirth with no additional intervention. Women > 34 < 39 weeks gestation, with a singleton, viable fetus, vertex presentation, who are not in active labour or planning a vaginal birth are eligible to participate. Allocation concealment is achieved using telephone randomisation. Participants assigned to hypnosis groups are trained as near as possible to 37 weeks gestation. Group allocations are concealed from treating obstetricians, anaesthetists, midwives and those personnel collecting and analysing data. Our sample size of 135 women / group gives the study 80% power to detect a clinically relevant fall of 20% in the number of women requiring pharmacological analgesia - the primary endpoint. We estimate that approximately 5-10% of women will deliver prior to receiving their allocated intervention. We plan to recruit 150 women / group and perform interim analyses when 150 and 300 participants have been recruited. All participants will be analysed according to the "Intention to treat" principle with comprehensive pre-planned cost- benefit and subgroup analyses.

Discussion: If effective, hypnosis would be a simple, inexpensive way to improve the childbirth experience, reduce complications associated with pharmacological interventions, yield cost savings in maternity care, and provide evidence to guide clinical practice.

Conditions
Pregnancy, Labor
Being tested
antenatal hypnosis + audio compact disc on hypnosis, Audio compact disc on hypnosis
Keywords
Hypnosis, Hypnotherapy, Childbirth, Analgesia
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • antenatal hypnosis + audio compact disc on hypnosisBehavioural

  • Audio compact disc on hypnosisBehavioural

Study groups in NCT00282204
Study groupRoleWhat they receive
ControlNo interventionUsual care control
Hypnosis + CDExperimentalHypnosis plus audio cd on hypnosis
Receives: Behavioral: antenatal hypnosis + audio compact disc on hypnosis
Audio CD on HypnosisActive comparatorAudio CD on hypnosis sessions weekly on three occasions after 34 weeks gestation
Receives: Behavioral: Audio compact disc on hypnosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The use of pharmacological analgesia during labour and childbirth will be collected from the birth register where all analgesia is documented by the attending midwife

    Measured: Within 24 hours of the birth

Secondary outcomes (13)
  1. 1. Maternal rating of the overall pain experienced during labour and childbirth

    Measured: Usually within 48 hours or before discharge from hospital

  2. 2. Mode of delivery

    Measured: Within 24 hours of the birth

  3. 3. Use of oxytocics

    Measured: Within 24 hours of the birth

  4. 4. Postnatal depression

    Measured: At 6 weeks and 6 months postnatal

  5. 5. Maternal anxiety

    Measured: At 6 weeks and 6 months postnatal

  6. 6. Neonatal Apgar score at 5 minutes < 7

    Measured: within 24 hours of birth

  7. 7. Maternal admission to the High Dependency Unit (HDU) or the Intensive Care Unit (ICU)

    Measured: within 24 hours of birth

  8. 8. Maternal rating whether the birth experience was. Worse / better / same as expected

    Measured: within 24 hours of birth

  9. 9. Maternal rating of control during the labour during the birth

    Measured: within 24 hours of birth

  10. 10. Maternal rating whether the birth was rated positive or negative experience

    Measured: within 24 hours of birth

  11. 11. Length of neonatal nursery stay

    Measured: within 24 hours of birth

  12. 12. Length of maternal stay in hospital

    Measured: within 6 months of the birth

  13. 13. Number of women breast feeding at discharge from hospital and at 6 weeks and 6 months

    Measured: 6 months after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2006 (estimated)
  2. Study startDec 2005
  3. Primary completionDec 2010
  4. Study completionDec 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
448 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00282204
Sponsor's protocol ID
ACTRN012605000018617
Status last verified
Dec 2010
First submitted
24 Jan 2006
Last updated
29 Jun 2012
Results posted
No
Data monitoring committee
Yes

Publications

  • Cyna AM, Andrew MI, Robinson JS, Crowther CA, Baghurst P, Turnbull D, Wicks G, Whittle C. Hypnosis Antenatal Training for Childbirth (HATCh): a randomised controlled trial [NCT00282204]. BMC Pregnancy Childbirth. 2006 Mar 5;6:5. doi: 10.1186/1471-2393-6-5.

    PubMed 16515709

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing antenatal hypnosis + audio compact disc on hypnosis and Audio compact disc on hypnosis in people with Pregnancy and Labor, run by Women's and Children's Hospital, Australia at 1 site in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jun 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The use of pharmacological analgesia during labour and childbirth will be collected from the birth register where all analgesia is documented by the attending midwife (time frame: Within 24 hours of the birth). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00282204, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2012; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in